Amphastar Pharmaceuticals Inc
F:29A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amphastar Pharmaceuticals Inc
F:29A
|
US |
|
Duke Royalty Ltd
F:B34
|
GG |
|
F
|
Fomento de Construcciones y Contratas SA
XMUN:FCC
|
ES |
Intrinsic Value
The intrinsic value for
Amphastar Pharmaceuticals Inc (29A) under the Base Case is 34.95 EUR.
Compared with the current market price of 15.68 EUR, the stock appears
Undervalued by 55% .
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Amphastar Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Amphastar Pharmaceuticals Inc
Earnings Waterfall
Amphastar Pharmaceuticals Inc
The intrinsic value for
Amphastar Pharmaceuticals Inc (29A) under the Base Case is 34.95 EUR.
Compared with the current market price of 15.68 EUR, the stock appears Undervalued by 55% .